SUPPLEMENTARY MATERIALS

Published: 4 September 2024| Version 1 | DOI: 10.17632/6mjv8t8y8b.1

Contributors:

Patricia Carney, Gordon B Cutler, Jr, Kristi Schneider,

, Richard DiMarchi

Description

MBX 2109, a Once-Weekly Parathyroid Hormone Replacement Therapy Prodrug: Phase 1, First-in-Human, Randomized Trial

Files

Categories

Hypoparathyroidism

Funding

MBX Biosciences, Inc.

Licence